Citation: M. Fiegl et al., MOLECULAR CYTOGENETICS IN CANCER-RESEARCH AND CLINICAL ONCOLOGY - HEMATOLOGICAL MALIGNANCIES, Onkologie, 21(3), 1998, pp. 190-197
Authors:
ROKA S
FIEGL M
ZOJER N
FILIPITS M
SCHUSTER R
STEINER B
JAKESZ R
HUBER H
DRACH J
Citation: S. Roka et al., ANEUPLOIDY OF CHROMOSOME-8 AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IS A RECURRENT FINDING IN PRIMARY AND METASTATIC BREAST-CANCER, Breast cancer research and treatment, 48(2), 1998, pp. 125-133
Authors:
STINDL R
FIEGL M
REGELE H
GISSLINGER H
BREITENSEHER MJ
FONATSCH C
Citation: R. Stindl et al., ALVEOLAR RHABDOMYOSARCOMA IN A 68-YEAR-OLD PATIENT IDENTIFIED BY CYTOGENETIC ANALYSIS BONE-MARROW, Cancer genetics and cytogenetics, 107(1), 1998, pp. 43-47
Authors:
ZOJER N
FIEGL M
MULLAUER L
CHOTT A
ROKA S
ACKERMANN J
RADERER M
KAUFMANN H
REINER A
HUBER H
DRACH J
Citation: N. Zojer et al., CHROMOSOMAL IMBALANCES IN PRIMARY AND METASTATIC PANCREATIC-CARCINOMAAS DETECTED BY INTERPHASE CYTOGENETICS - BASIC FINDINGS AND CLINICAL ASPECTS, British Journal of Cancer, 77(8), 1998, pp. 1337-1342
Authors:
DRACH J
ACKERMANN J
FRITZ E
KROMER E
SCHUSTER R
GISSLINGER H
DESANTIS M
ZOJER N
FIEGL M
ROKA S
SCHUSTER J
HEINZ R
LUDWIG H
HUBER H
Citation: J. Drach et al., PRESENCE OF A P53 GENE DELETION IN PATIENTS WITH MULTIPLE-MYELOMA PREDICTS FOR SHORT SURVIVAL AFTER CONVENTIONAL-DOSE CHEMOTHERAPY, Blood, 92(3), 1998, pp. 802-809
Authors:
ZOJER N
FIEGL M
ANGERLER J
MULLAUER L
GSUR A
ROKA S
PECHERSTORFER M
HUBER H
DRACH J
Citation: N. Zojer et al., INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IMPROVES THE DETECTION OF MALIGNANT-CELLS IN EFFUSIONS FROM BREAST-CANCER PATIENTS, British Journal of Cancer, 75(3), 1997, pp. 403-407
Citation: M. Fiegl, MECHANISMS OF IMMUNOMODULATION BY GLUCOCO RTICOID-MEDIATED GENE-REGULATION, Wiener Klinische Wochenschrift, 108(2), 1996, pp. 48-50
Authors:
DRACH J
GSUR A
HAMILTON G
ZHAO SR
ANGERLER J
FIEGL M
ZOJER N
RADERER M
HABERL I
ANDREEFF M
HUBER H
Citation: J. Drach et al., INVOLVEMENT OF P-GLYCOPROTEIN IN THE TRANSMEMBRANE TRANSPORT OF INTERLEUKIN-2 (IL-2), IL-4, AND INTERFERON-GAMMA IN NORMAL HUMAN T-LYMPHOCYTES, Blood, 88(5), 1996, pp. 1747-1754
Authors:
FIEGL M
STRASSERWOZAK E
GELEY S
GSUR A
DRACH J
KOFLER R
Citation: M. Fiegl et al., GLUCOCORTICOID-MEDIATED IMMUNOMODULATION - HYDROCORTISONE ENHANCES IMMUNOSUPPRESSIVE ENDOGENOUS RETROVIRAL PROTEIN (P15E) EXPRESSION IN MOUSE IMMUNE CELLS, Clinical and experimental immunology, 101(2), 1995, pp. 259-264
Authors:
STRASSERWOZAK EMC
HATTMANNSTORFER R
HALA M
HARTMANN BL
FIEGL M
GELEY S
KOFLER R
Citation: Emc. Strasserwozak et al., SPLICE-SITE MUTATION IN THE GLUCOCORTICOID RECEPTOR GENE CAUSES RESISTANCE TO GLUCOCORTICOID-INDUCED APOPTOSIS IN A HUMAN ACUTE LEUKEMIC-CELL LINE, Cancer research, 55(2), 1995, pp. 348-353
Authors:
DRACH J
SCHUSTER J
NOWOTNY H
ANGERLER J
ROSENTHAL F
FIEGL M
ROTHERMUNDT C
GSUR A
JAGER U
HEINZ R
LECHNER K
LUDWIG H
HUBER H
Citation: J. Drach et al., MULTIPLE-MYELOMA - HIGH-INCIDENCE OF CHROMOSOMAL ANEUPLOIDY AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION, Cancer research, 55(17), 1995, pp. 3854-3859
Authors:
FIEGL M
TUENI C
SCHENK T
JAKESZ R
GNANT M
REINER A
RUDAS M
PIRCDANOEWINATA H
MAROSI C
HUBER H
DRACH J
Citation: M. Fiegl et al., INTERPHASE CYTOGENETICS REVEALS A HIGH-INCIDENCE OF ANEUPLOIDY AND INTRA-TUMOR HETEROGENEITY IN BREAST-CANCER, British Journal of Cancer, 72(1), 1995, pp. 51-55
Authors:
DRACH J
ANGERLER J
SCHUSTER J
ROTHERMUNDT C
THALHAMMER R
HAAS OA
JAGER U
FIEGL M
GEISSLER K
LUDWIG H
HUBER H
Citation: J. Drach et al., INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHYOF UNDETERMINED SIGNIFICANCE, Blood, 86(10), 1995, pp. 3915-3921
Authors:
DITTRICH C
ZIFKO U
FAZENY B
FIEGL M
GRISOLD W
HUBER H
Citation: C. Dittrich et al., VINORELBINE AFTER PACLITAXEL IN BREAST-CANCER - CROSS-RESISTANCE AND CUMULATIVE NEUROTOXICITY, Annals of oncology, 5(5), 1994, pp. 473-474